ALAFI CAPITAL CO LLC reported grant involving 3,529,192 derivative units of CalciMedica, Inc. at $0.00 for $0 on Aug 19, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
10% owner
10%
Filed Aug 24, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
3,529,192Series A Warrants
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
3,529,192Direct
Trade date
Aug 19, 2026Grant
Filed
Aug 24, 2026, 5:03 PM ET5-day reporting delay
Accession
0000912282-26-001157Code A · Transaction 84089
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 19, 2026Grant3,529,192$0.00$0Trade 84090
2 transaction rows in this filing. Joint filers share the same rows.

CALC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CALC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +27%1w ago +11%1d ago +15%
Returns since7d +289%30d +225%90d180d1y

Footnotes in full

F1: The issue date of the Series A Warrants is August 19, 2026. F2: The expiration of these Series A Warrants is the earlier of (i) 18 months after the closing date of the Private Placement and (ii) 30 days following the Issuer's public announcement of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480. F3: The issue date of the Series B Warrants is August 19, 2026.